UNSPSC 51341602: Tromantadine

This classification denotes an antiviral agent with the molecular formula C16H28N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier H191JFG8WA, chemically known as 2-(2-(dimethylamino)ethoxy)-n-tricyclo(3.3.1.13,7)dec-1-ylacetamide but generally known as tromantadine, which bears US NIH Compound Identifier 64377. European Medicines Agency schedules Tromantadine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11335MIG.

UNSPSC 51341602 Tromantadine is a Commodity code for a specific antiviral pharmaceutical product, but recent state and local opportunities tagged under it show minimal relevant activity — the posted records name pharmaceutical procurements that do not involve tromantadine and appear to reflect data classification or tagging mismatches rather than actual demand for this drug. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical warehouse contract through MMCAP Infuse to Chartwell Rx LLC in August 2026 for Doxycycline Hyclate and Ciprofloxacin Hydrochloride (both antibiotics, not antivirals), and Seminole County, Florida posted an IFB in June 2026 for Naloxone and drug deactivation systems — neither solicitation involves tromantadine procurement.

State and local procurement activity under this code does not support a pursue decision at present. The mismatch between the code's specific drug scope and the actual pharmaceutical categories appearing in recent awards and solicitations signals either shallow or mislabeled opportunity flow. No open solicitations for tromantadine appear in the recent records, and the two posted opportunities address different therapeutic categories and issuing bodies (a state health department and a county community health program). Geographic spread and issuing-body patterns cannot be reliably characterized from opportunities unrelated to the code's intended commodity. Track this code for future activity if state or local emergency-preparedness or public-health initiatives explicitly call for antiviral stockpiling or pandemic-response protocols.